UPDATE 2-Biogen delays Alzheimer's drug filing plans, shares fall 11%
April 22, 2020 at 10:45 AM EDT
Biogen Inc on Wednesday delayed the filing for marketing approval of its experimental Alzheimer's disease drug, saying that it needed more time to prepare the data before submission.